The decline in Q4 revenue was attributable to a decrease in Audience Monetization revenues and lower Other Initiatives revenues. The revenue was in line with analyst expectations, per Fiscal.ai.
The company received a Complete Response Letter from the U.S. Food and Drug Administration for its New Drug Application seeking approval of Anaphylm, a sublingual film to treat severe Type I allergic reactions.
The analyst highlighted that major pharmaceutical companies are already pursuing GLP-1-based therapies for MASH, but he believes efruxifermin could complement these treatments.
Small-cap stocks are surging, with the iShares Russell 2000 ETF up 9% in the last 5 days. This is due to expectations of Fed rate cuts, causing investors to rotate from tech to small caps.
What a day for Meta! I was planning to add to my position, but the volume was too low. I would have been shaken out of most of it for the swing before it could become this position trade.
Allianz chief economic adviser and well-known economist Mohamed El-Erian pays close attention to the bond market, as it can often be an indicator for future stock market performance and broader economic conditions.
In this piece we remind readers that it is not rates or the Federal Reserve Bank that drives markets, but rather net fund-transfers from the Treasury that fee bull markets.
